Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Safety across the full program was consistently favorable: adverse events, primarily mild headache and gastrointestinal symptoms, occurred at rates comparable to placebo, with no treatment-related discontinuations, no IGF-1 elevation, and no impact on glucose metabolism
Certificate of Analysis (COA): See Images
By reducing inflammation in the gut, BPC-157 may help alleviate symptoms such as abdominal pain and bloating, leading to improved digestive comfort
2011 Aug;28(8):1857-65
US$ 20.59
US$ 25.92
US$ 27.65
US$ 24.90
US$ 22.39
US$ 25.22
US$ 24.74
